XBIO: Xenetic Biosciences, Inc. Stock

by  •  • Comments Off on XBIO: Xenetic Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.74
Enterprise Value ($M) -0.43
Book Value ($M) 5.12
Book Value / Share 3.32
Price / Book 0.92
NCAV ($M) 4.81
NCAV / Share 3.12
Price / NCAV 0.98

Profitability (mra)
Return on Invested Capital (ROIC) -0.72
Return on Assets (ROA) -0.39
Return on Equity (ROE) -0.42

Liquidity (mrq)
Quick Ratio 8.20
Current Ratio 8.20

Balance Sheet (mrq) ($M)
Current Assets 5.48
Assets 5.79
Liabilities 0.67
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.50
Operating Income -4.20
Net Income -3.96
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -2.82
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2025-05-13 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A Amendment No. 2
2025-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A Amendment No. 1
2025-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-04 61 2,818 2.16
2025-06-03 2,460 7,264 33.87
2025-06-02 8,082 28,573 28.29
2025-05-30 1 798 0.13

(click for more detail)

Similar Companies
VYNE – VYNE Therapeutics Inc. WHWK – Whitehawk Therapeutics, Inc.
WINT – Windtree Therapeutics, Inc. XCUR – Exicure, Inc.
ZURA – Zura Bio Limited


Financial data and stock pages provided by
Fintel.io